Quantcast

Latest BSD Stories

2008-07-31 09:01:26

SALT LAKE CITY, July 31, 2008 (PRIME NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that the company's most advanced cancer treatment system, the BSD-2000/3D/MR, has been adapted to treat children with cancer, as well as adults. To accommodate the treatment of children, BSD Medical has developed sophisticated treatment applicators that are specifically sized for small and medium-sized children, and that are capable of delivering pediatric cancer therapy during simultaneous...

2008-07-17 15:01:02

SALT LAKE CITY, July 17, 2008 (PRIME NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that a formal response has been hand delivered to the Food and Drug Administration (FDA) pertaining to the BSD-2000 Hyperthermia System submission that is currently in review by the FDA. The response followed an in-person meeting with the FDA management and reviewers in which the company's response strategy was discussed before the company made its formal response. On January 7, 2008, the...

2008-07-10 09:01:29

SALT LAKE CITY, July 10, 2008 (PRIME NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today announced that the company has filed its third quarter 10-Q report with the Securities and Exchange Commission and has released the following highlights of year-to-date results after three quarters of its fiscal year 2008: * Sales were up 66% compared to the prior year * Gross margin rose from 41% in the prior year to 63% for the current year * Operating expenses decreased, compared...

2008-07-03 09:01:19

BSD Medical Corp. (NASDAQ:BSDM) today announced the addition of seven new BSD-500 hyperthermia systems purchased by major cancer treatment center in the United States. The most recent purchase by the Massey Cancer Center at Virginia Commonwealth University located in Richmond, Virginia joins in a number of recent hyperthermia system sales in the United States. Other notable cancer care hospitals that have also purchased or installed BSD hyperthermia systems this year include: 1 Cleveland...

2008-06-30 09:03:37

BSD Medical Corporation (NASDAQ:BSDM) today provided an update on the status of the company's submissions to the Food and Drug Administration (FDA). BSD currently has two FDA submissions in progress, a premarket (PMA) submission for the BSD-2000 Hyperthermia System and a 510(k) premarket notification seeking FDA marketing clearance for the MicroThermX-100 Ablation System. On January 7, 2008 the company announced that it had received a letter from the FDA regarding its PMA submission for...

2008-06-25 09:03:33

BSD Medical Corp. (NASDAQ:BSDM) today announced that another BSD-2000 hyperthermia system has been purchased, installed and is now in use in China, at the Liaocheng Peoples Hospital located in Liaocheng City, in the Western Shandong Province of the People's Republic of China. The Liaocheng Peoples Hospital has recently added a 19-floor, state-of-the-art building equipped with the most up-to-date cancer imaging and therapy devices in the world. This hospital serves as the main cancer center to...

2008-06-18 09:01:17

BSD Medical Corp. (NASDAQ: BSDM) today reported that in the Annals of Oncology (Volume 19, Supplement 2, 2008), the European Society for Medical Oncology (ESMO) Clinical Treatment Guideline Working Group has published its relevant clinical treatment guidelines under "Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up." The guidelines highlight hyperthermia therapy as a treatment option for several types of soft tissue sarcomas. The ESMO Guidelines...

2007-11-20 09:01:08

BSD Medical Corp. (AMEX:BSM) today announced the installation of the first BSD-500 hyperthermia cancer therapy system in Switzerland at the Department of Radiation Oncology of Kantonsspital Aarau. The hospital joins BSD's growing family of prestigious global customers with the purchase and installation of the new hyperthermia therapy system. The BSD-500 will be used to increase the Department's cancer therapy technology, particularly in treating advanced and recurrent cancer patients....

2007-09-13 09:00:39

BSD Medical Corp. (AMEX: BSM) today announced that it has received an order for a new BSD-2000/3D/MR system to be installed at the University of Dusseldorf. This purchase was made possible by a multi-million Euro donation from the Parents' Initiative Pediatric Cancer Clinic. For more than 10 years the Dusseldorf pediatric oncology department has pioneered the application of hyperthermia therapy for treating children's cancers using a standard BSD-2000 for the treatment of soft tissue...

2007-07-10 15:15:58

SALT LAKE CITY, July 10 /PRNewswire-FirstCall/ -- BSD Medical Corp. today announced that Littleton Radiation Oncology has joined BSD Medical's growing group of U.S. customers, with their acquisition and installation of a BSD-500 Hyperthermia System in their Littleton, Colorado facility. Littleton is a suburb of Denver. This new system will increase their ability to treat cancer patients at their facility. "With a large and long time patient experience using hyperthermia therapy in...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.